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Nitrate toxicity causes methemoglobinemia, which is a wholly preventable disease.
Infants less than 4 months of age are at particular risk o f nitrate toxicity from  
contaminated water.
The widespread use of nitrate fertilizers increases the risk o f well-water contami­
nation in rural areas.
This monograph is one in a series of self-instructional publications designed to increase the primary care provider's 
knowledge of hazardous substances in the environment and to aid in the evaluation of potentially exposed 
patients. See page 21 for more information about continuing medical education credits and continuing education 
units.
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How to use this issue...
This issue begins with a composite case study that describes a realistic encounter with a patient. This description 
is followed by a pretest. The case study is further developed through Challenge questions at the end of each section. 
To benefit fully from this monograph, readers are urged to answer each question when it is presented. (Answers to 
the Pretest and Challenge questions are found on page 18.) The monograph ends with a posttest, which can be 
submitted to the Agency for Toxic Substances and Disease Registry (ATSDR) for continuing medical education 
(CME) credit orcontinuing education units (CEU). See page 21 forfurther instructions on howto receive these credits.
The objectives of this monograph on nitrates/nitrites are to help you:
□  Explain why nitrates/nitrites may be an acute and chronic health hazard
□  Describe the known factors contributing to nitrate/nitrite toxicity
□  Assess a patient's environmental or occupational exposure to nitrates/nitrites
□  Evaluate and treat nitrate/nitrite exposure
□  List sources of information on nitrates/nitrites
This issue is prepared with the assistance of those who share a common concern for physician education, public 
health, and the environment, including the following organizations: American Academy of Family Physicians (AAFP), 
American Academy of Pediatrics (AAP), American College of Emergency Physicians (ACEP), American College of 
Occupational Medicine (ACOM), American Medical Association (AMA), Association of State and Territorial Health 
Officials (ASTHO), and the Society of Teachers of Family Medicine (STFM). Final responsibility forthe contents and 
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Nitrate/nitrite toxicity
A 2-month-old infant with vomiting, diarrhea, tachypnea, and cyanosis
A 2-month-old female Infant is brought to your clinic in a rural area for a routine well-baby checkup. According 
to the child’s chart, she was delivered 2 weeks early because of maternal toxemia. There was no neonatal 
distress; her birth weight was 7 pounds and 11 ounces.
Today, the mother states that she has noticed an intermittent bluish discoloration of the baby’s lips, tip of the 
nose, and ears. Physical examination of the infant is negative for both cardiac murmurs and abnormalities 
on lung auscultation. A below-average weight gain is noted. Feedings have been 4 ounces of diluted formula 
every 2 hours. The infant has occasional loose stools. You instruct the parents to increase caloric feedings 
with vitamin and mineral supplements and to call you immediately if any further episodes of the bluish 
discoloration are observed.
Approximately 3 weeks later, the baby’s frantic parents call your office; the infant is crying incessantly and 
has vomiting and profuse diarrhea. When the baby is brought to your clinic a few minutes later, she is afebrile 
but has tachypnea, cyanosis, and drowsiness. Her blood pressure is 78/30 mm Hg (normal 50th percentile 
for her age is 80/46 mm Hg), heart rate is 140/min, and respiration rate is 40/min. An ambulance is summoned 
and 100% oxygen by face mask is administered; however, no improvement in the cyanosis is noted on her 
arrival at the hospital emergency department.
The examining emergency physician now notes a grade I l/VI systolic murmur and central cyanosis, which has 
not improved despite administration of 100% oxygen for nearly 1 hour. There is no evidence of cardiac failure, 
atelectasis, pneumonitis, or pneumothorax. Therapy is started, which results in a dramatic resolution of the 
cyanosis. The infant is discharged on the second hospital day with no evidence of central nervous system 
hypoxic damage.
(a) What was the most likely cause of this infant's cyanosis?
(b) What laboratory tests, either obtained during the hospitalization or ordered subsequently, would 
assist in confirming the diagnosis?
(c) What steps, if  any, can be taken to prevent a recurrence of cyanosis and distress in this infant?





□  Shallow, rural domestic wells are 
most likely to be contaminated 
with nitrates, especially in areas 
where nitrogen-based fertilizers 
are in widespread use.
□  Other nitrate sources in well 
water include seepage from 
septic sewer systems.
□  Foodstuffs contaminated with 
nitrites and sausage preserved 
with nitrates and nitrites have 
caused symptomatic 
methemoglobinemia in children.
□  Deliberate abuse of volatile 
nitrite inhalants can cause 
severe methemoglobin­
emia and death.
Nitrate (N 03~) and nitrite (N02") are naturally occurring inorganic 
ions, which are part of the nitrogen cycle. Wastes containing organic 
nitrogen are decomposed in soil or water by microbial action to first 
form ammonia, which is then oxidized to nitrite and nitrate. Because 
nitrite is easily oxidized to nitrate, it is nitrate that is predominantly 
found in groundwater and surface waters. Contamination with nitro­
gen-containing fertilizers, including anhydrous ammonia as well as 
animal or human natural organic wastes, can raise the concentration 
of nitrate in water. Nitrate-containing compounds in the soil are 
generally soluble and readily migrate with groundwater.
In agricultural areas, nitrogen-based fertilizers are a major source of 
contamination for shallow groundwater aquifers that provide drinking 
water. A 1990 Environmental Protection Agency (EPA) survey found 
that about 1.2% of community wells and about 2.4% of rural 
domestic wells had nitrate concentrations in excess of federal 
regulatory limits, (see page 15) A similar survey conducted in Iowa 
indicated that about 18.3% of rural domestic wells contained con­
centrations of nitrate above the regulatory level. Other sources of 
nitrate contamination are organic animal wastes and contamination 
from septic sewer systems, especially in wells less than 100 feet 
deep. During spring melt or drought conditions, both domestic wells 
and public water systems using surface water may have increased 
nitrate concentrations.
Although vegetables are seldom a source of acute toxicity, they 
account for more than 70% of the nitrates in a typical human diet. 
Cauliflower, spinach, collard greens, broccoli, and root vegetables 
have a naturally greater nitrate content than other plant foods. The 
remainder of the nitrate in a typical diet comes from drinking water 
(about 21%) and from meat and meat products (about 6%) in which 
sodium nitrate is used as a preservative and color-enhancing agent.
Symptomatic methemoglobinemia has occurred in children who 
have eaten sausage heavily treated with nitrates and nitrites. For 
infants, the major source of nitrate exposure is drinking water used 
to dilute formula.
Accidental exposure to nitrites in chemical laboratories and inges­
tion in suicide attempts have been described. Deliberate abuse of 
volatile nitrites (amyl, butyl, and isobutyl nitrites) as psychedelics or 
aphrodisiacs occurs widely; these agents are known by street 
names such as “snappers,” “poppers,” “Locker Room,” and “Rush.”
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Nitrate or nitrite exposure also may occurfrom certain medications. 
Infants and children are especially susceptible to nitrate exposure 
through topical silver nitrate used in burn therapy. Other medica­
tions implicated in cases of nitrate or nitrite toxicity are quinone 
derivatives (antimalarials), nitroglycerine, bismuth subnitrite 
(antidlarrheal), ammonium nitrate (diuretic), amyl and sodium nitrites 
(antidotes for cyanide and hydrogen sulfide poisoning), and 
isosorbide dinitrate/tetranitrates (vasodilators used in coronary 
artery disease therapy). (See Table 1.)
Sodium nitrite used as an anticorrosive agent in cooling fluids, 
ammonium nitrate found in cold packs, and nitrous gases used in 
arc welding are other possible sources of exposure. An ethyl nitrite 
folk remedy called "sweet spirits of nitre" has caused fatalities. 
Serious poisoning and death have occurred when sodium nitrate 
was mistaken for table salt and Ingested with food.
Table 1. Reported inducers of methemoglobinemia
AGENT SOURCE/USE
Inorganic nitrates/nitrites Contaminated well water 
Meat preservatives 
Vegetables— carrot juice; spinach 
Silver nitrate burn therapy 
Industrial salts
Contaminants of nitrous oxide 
canisters for anesthesia
Organic nitrites
Butyl/isobutyl nitrite Room deodorizer propellants
Amyl nitrite Inhalant in cyanide antidote kit
Nitroglycerine Oral, sublingual, or transdermal 
pharmaceuticals for treatment of angina
Others
Aniline/aminophenols Laundry ink
Nitrobenzene Industrial solvents; gun-cleaning products





p-Aminosalicylic acid Bactericide (tuberculostatic)
Naphthalene Mothballs
Copper sulfate Fungicide for plants, seed treatment
Resorcinol Antiseborrheic, antipruritic, antiseptic
Chlorates Matches, explosives, pyrotechnics
Combustion products Fires
Adapted from: Dabney BJ, Zelarney PT, Hall AH. Evaluation and treatment of patients exposed to systemic 
asphyxiants. Emergency Care Quarterly 1990;6(3):65-80.
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(1) What questions will you ask the parents of the infant in the case study to help determine the 
cause o f the cyanosis?
(2) If well water used to dilute formula is implicated in the cyanosis, what are some possible causes 
of its nitrate contamination?
Who’s at Risk
Infants less than 4 months of age 
are at the greatest risk for nitrate 
toxicity.
About 1% to 2% of the U.S. 
population that uses drinking 
water from public water systems 
may be exposed to nitrates in 
excess of the EPA-recommended 
maximum concentration.
Infants less than 4 months of age who are fed formula diluted with 
water from rural domestic wells are especially prone to developing 
acute acquired methemoglobinemia from nitrate exposure. The pH 
of the gut is normally higher in infants than in older children and 
adults. Higher gut pH enhances the conversion of ingested nitrate to 
more potent nitrite; gastroenteritis with vomiting and diarrhea can 
exacerbate nitrite formation.
A large proportion of hemoglobin in infants is in the fetal hemoglobin 
form, which is more readily oxidized by nitrites to methemoglobin 
than adult hemoglobin is. In infants, NADH'-dependent methemo­
globin reductase, the enzyme responsible for reduction of methemo­
globin back to normal hemoglobin, has only about half the activity 
present in adults. These factors combine to place young infants who 
are fed formula diluted with nitrate-contaminated well water at the 
greatest risk of toxicity. There is little evidence that breast-fed infants 
develop methemoglobinemia from exposure to nitrates ingested by 
the nursing mother.
* Reduced form of nicotinimide adenine dinucleotide
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The first reported case of fatal acquired methemoglobinemia in an 
infant due to ingestion of nitrate-contaminated well water occurred in 
1945. Since that time about 2,000 similar cases of acquired methemo­
globinemia in young infants have been reported worldwide; about 
10% of such cases result in fatality. The most recently reported U.S. 
case of infant mortality due to this source was in 1987.
In pregnant women, the level of methemoglobin increases from the 
normal (0.5% to 2.5% of total hemoglobin) to a maximum of 10.5% 
at the 30th week of pregnancy and subsequently declines to normal 
after delivery. Thus, pregnant women may be more sensitive to the 
induction of clinical methemoglobinemia by nitrites or nitrates at or 
near the 30th week of pregnancy.
It has been estimated that 1% to 2% of the U.S. population using 
drinking water from public water systems may be consuming nitrates 
in excess of the EPA-recommended maximum concentration. It has 
also been estimated that residents in as many as 603,000 homes 
consume drinking water from nitrate-contaminated domestic wells. 
Although suppliers of public water sources are required to monitor 
nitrate concentrations regularly, rural wells often are not routinely 
tested for nitrates.
Cha(Ceng>
(3) What recommendations can you make to the infant's family in the case study to prevent further 
cyanotic episodes?
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In humans, ingested nitrate is rapidly absorbed from the proximal 
small bowel and distributed throughout the body. Nitrate then 
enters the large bowel from the blood, where it is rapidly converted 
to highly reactive nitrite, in part by fecal microorganisms. The 
formed nitrite is reabsorbed into the blood, where it reacts with the 
ferrous (Fe2+) iron of deoxyhemoglobin, forming methemoglobin 
with iron in the ferric (Fe3+) valence state. Ferric iron is unable to 
transport oxygen.
Nitrates are rapidly converted in the liver to denitrated metabolites 
and inorganic nitrites, which are then excreted in urine. Approxi­
mately 60% to 70% of an ingested nitrate dose is excreted in urine 
within the first 24 hours. About 25% is excreted in saliva through an 
active blood nitrate transport system and potentially is reabsorbed. 
Half-lives of parent nitrate compounds are usually less than 1 hour; 
half-lives of metabolites range from 1 to 8 hours.
□  In vivo conversion of nitrates to 
nitrites significantly enhances 
nitrates’ methemoglobin- 
Inducing potency.
□  Nitrates are excreted rapidly in 
the urine.
Chatteng^
(4) What factors make infants less than 4 months o f age more susceptible to developing methemoglo­




Unless favorable conditions exist for reducing nitrate to nitrite In the 
gut (i.e., high pH, proper intestinal microbial flora), ingested nitrate 
( N O 3 -)  is metabolized and excreted without producing apparent 
adverse effects. The effects of nitrite (N0 2-) are the same whether 
nitrite-containing compounds are ingested or inhaled, or nitrite is 
produced in vivo from nitrate.
Hematologic Effects
The principal mechanism of nitrite toxicity is the oxidation of the 
ferrous iron (Fe2+) in deoxyhemoglobin to the ferric (Fe3+) valence 
state, producing methemoglobin. Methemoglobin cannot reversibly 
bind or transport circulating oxygen. Depending on the percentage of 
total methemoglobin in oxidized form, the clinical picture is one of 
oxygen deprivation with cyanosis, cardiac dysrythmias and circula­
tory failure, and progressive central nervous system (CNS) effects. 
The CNS effects may range from mild dizziness and lethargy to coma 
and convulsions.
Hemoglobin protein may also be oxidized, causing denaturation and 
erythrocyte hemolysis and resulting in hemolytic anemia. The dena­
tured protein is visible on special peripheral blood stains as Heinz 
bodies (minute bodies sometimes seen in erythrocytes by the dark 
illumination method). Many agents that induce methemoglobin can 
also induce a sulfhemoglobinemia, which is usually benign but may 
confound the diagnosis. Sulfhemoglobin may produce cyanosis that 
is apparent at concentrations as low as 3% to 5% total hemoglobin.
Two enzymes (one NADH-dependent, the other NADPH-dependent) 
are normally present that reduce methemoglobin back to hemoglobin. A 
physiologic methemoglobinemia (1 % to 2% of total hemoglobin) is 
typical in humans as a result of exposure to oxidizing substances 
and diet. A rare congenital methemoglobinemia^ 0%to 50% of total 
hemoglobin) may be found in persons with either hemoglobin M 
disease* or a deficiency of NADH-dependent methemoglobin reduc­
tase. Acquired methemoglobinemia is caused by exposure to oxidiz­
ing substances including nitrates and nitrites. Persons with a 
deficiency of NADH-dependent reductase may be more susceptible 
to developing symptomatic methemoglobinemia after exposure to 
nitrates and nitrites.
* A disease caused by a group of abnormal hemoglobins in which a single amino add 
substitution favors the formation of methemoglobin, in spite of normal quantities of 
methemoglobin reductase.
□  Acuta acquired methemoglobin­
emia is the most Important 
adverse health effect caused by 
excessive nitrate exposure.
□  Some methemoglobin- 
inducing agents can also cause 




□  Hypotension, shock, and cardiac 
arrhythmias may occur in cases 
of severe methemoglobinemia.
□  Severe methemoglobinemia 
may lead to metabolic 
acidosis.
□  Chocolate-brown cyanosis is 
a hallmark of methemoglobin­
emia.
Cardiovascular Effects
in large doses, nitrite is an excellent vasodilator due to its relaxing 
action on vascular smooth muscle; hypotension and shock can result. 
Systolic flow murmurs may be heard on auscultation in persons with 
severe methemoglobinemia, which may develop with too-rapid intra­
venous administration of sodium nitrite (used as an antidote for 
cyanide and hydrogen sulfide poisoning) or sodium nitroprusside 
(used in hypertensive crisis therapy). In patients who have inhaled 
volatile nitrites, transient electrocardiographic changes (T-wave inver­
sions and ST-segment depression) may be noted.
Respiratory Effects
Metabolic acidosis develops in cases of severe methemoglobinemia, 
especially in young infants or when hypotension and shock are 
present. Dyspnea and tachypnea are common findings in patients 
with significant methemoglobinemia. Respiratory tract irritation may 
occur in patients who abuse volatile nitrites.
Other Effects
A chocolate-brown or slate-gray central cyanosis (involving the trunk 
and proximal portions of the limbs, as well as the distal extremities and 
mucous membranes) is one of the hallmarks of methemoglobinemia. 
This cyanosis is due to the dark chocolate-brown color of methemo- 
globin itself and usually becomes noticeable at a concentration of 10% 
to 15% of total hemoglobin.
Concern has been expressed about the cancer-causing potential of 
nitrates and nitrites used as preservatives and color-enhancing agents 
in meats. Nitrates can react with amino acids to form nitrosamines, 
which have been reported to cause cancer in animals. However, data 
from human and experimental animal studies have failed to provide 
conclusive evidence that nitrate or nitrite ingestion causes carcino­




History and Physical Examination
□  Cyanosis that fails to improve 
with administration of 100%
Evaluation of a patient with suspected nitrate/nitrite exposure in­
cludes a complete medical history and physical examination. Clues 
to potential exposure are often obtained by reviewing the following 
items with the patient or family:
oxygen is a sentinel finding in 
cases of methemoglobinemia.
• Location of dwelling (urban, suburban, rural)
• Drinking water source and supply (in case of well water: depth,
location, type of well construction, and frequency of microbio­
logie and nitrate testing)
• Surrounding activities (agricultural, industrial) and proximity to
drinking-water source
• Type of sewer system (municipal, septic) and proximity to
drinking-water source
• Occupations, avocations, and hobbies of family members
• Nutritional status (for infants: type of formula, feeding regimen,
and source of dilution water)
• Family history, including recent use of medications by infant
and mother
• History of recent gastroenteritis with vomiting or diarrhea
Physical examination should include special attention to the color of 
the skin and mucous membranes. If a history of gastroenteritis is 
present (especially in infants), evaluate the patient for the possible 
presence of dehydration (poor skin turgor, sunken fontanelle, dry 
mucous membranes). All cyanotic patients should be assessed for 
possible cardiac and lung disease (cardiac murmurs, gallops, 
arrhythmias: rales, rhonchi, wheezes, dullness or hyperresonance in 
the chest). A central chocolate-brown or slate-gray cyanosis that 
does not respond to administration of 100% oxygen is indicative of 
methemoglobinemia; cyanosis due to cardiorespiratory compromise 
most often improves with administration of 100% oxygen.
In young infants, look for labored breathing, respiratory exhaustion, 
hypotension, below-average weight gain, and failure to meet de­
velopmental milestones. Gastroenteritis can increase the rates of 




□  Signs and symptoms of 
methemoglobinemia are 
related to the percentage of 





10%-20% Central cyanosis of limbs/trunk; 
usually asymptomatic
20%-45% CNS depression (headache, dizziness, 
fatigue, lethargy, syncope), dyspnea
45%-55% Coma, arrhythmias, shock, convulsions
>70% High risk of mortality
From: Dabney BJ, Zelarney PT, Hall AH. Evaluation and treatment of patients 
exposed to systemic asphyxiants. Emergency Care Quarterly 1990;6(3):65-80.
The lips and mucous membranes of patients with nitrate/nitrite 
toxicity usually have more of a brownish than a bluish cast. Dyspnea, 
especially on exertion, is common. Varying degrees of central 
nervous system depression may be present. The cardiac and 
pulmonary examinations are usually normal, but systolic flow mur­
murs may be detected. Cardiac arrhythmias and hypotension may 
occur in patients with severe poisoning, although death from methe­
moglobinemia alone is uncommon, except in infants.
Signs and Symptoms
Signs and symptoms of methemoglobinemia can be directly corre­
lated with the percentage of total hemoglobin in the oxidized form 
(Table 2).
Table 2. Signs and symptoms of methemoglobinemia
Laboratory Evaluation
Most commonly, a drop of the patient’s blood is placed on a piece Q Methemoglobinemia results in
of filter paper alongside a drop of blood from a normal individual; distinct changes in blood color
when dry, the methemoglobin-containing blood will turn a deep and oxygen-carrying capacity.
chocolate-brown or slate-gray color in comparison. A tube of
methemoglobin-containing blood will not turn red when shaken in
air or when oxygen is bubbled through it; whereas blood that is dark
because of a high content of normal deoxyhemoglobin will turn red.
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□  Measurements of nitrates 
or nitrites in blood, urine, 
or saliva are not clinically 
useful.
□  The most useful diagnostic 
test for nitrate toxicity is a 
blood methemoglobln level.
□  Percent 02 saturation is 
an important but nonspe­
cific finding in patients with 
methemoglobinemia.
Screening Tests
• Examination of blood color
• Determination of the calculated versus measured
arterial saturation gap
• Hemoglobin and hematocrit
• Serum-free hemoglobin (for hemolysis detection)
• Serum haptoglobin (for hemolysis detection)
• Heinz bodies on peripheral blood smear
• Urinalysis
Specialized Tests
• Determination of methemoglobin level
• Tests for causes of congenital methemoglobinemia:
—  Hemoglobin electrophoresis
—  Activity of NADH-dependent methemoglobin reductase
• Tests for causes of failure of methylene blue therapy (see 
Treatment and Management, page 13):
—  Activity of glucose-6-phosphate dehydrogenase
(G-6-PD)
—  Activity of NADPH-dependent methemoglobin reduc­
tase
—  Sulfhemoglobin blood level (not readily available for
clinical use)
Direct Biologic Indicators
Although 80% to 90% of the body's excretion of nitrate is through 
urine and saliva, biologic nitrate or nitrite levels are generally not 
useful for diagnostic purposes. However, urinary and salivary nitrate 
concentrations can be important indicators of exposure requiring 
remedial action. The correlation between blood nitrite and methemo­
globin is not usually linear at lower nitrite concentrations since a 
certain minimum amount of nitrite must enterthe bloodstream before 
a measurable increase in methemoglobin concentration can be 
detected.
Indirect Biologic Indicators
The methemoglobin level in blood is the most useful screening, as well 
as diagnostic, test for nitrate toxicity. Methemoglobin can be mea­
sured in whole blood using a visible spectrophotometer (or Co- 
Oximeter) at 635 nanometers. To express the methemoglobin level as 
a percentage, total hemoglobin content of the blood sample also must 
be determined. Oximeters used to measure methemoglobin levels 
may falsely report sulfhemoglobin as methemoglobin. Although 
sulfhemoglobinemia is seldom severe enough to be life-threatening,
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its presence can explain some methylene blue treatment (see Treat­
ment and Management, page 13) failures. For the evaluation of sus­
pected congenital methemoglobinemia, hemoglobin electrophoresis 
is helpful.
In patients with methemoglobinemia, the partial pressure of oxygen 
(PO2) is usually normal despite the presence of an abnormal 
hemoglobin that cannot bind or transport oxygen. The percent O2 
saturation calculated by some blood-gas instruments from the p02 , 
or calculated manually with a nomogram, will be normal. However, 
the percent O2 saturation actually measured with a Co-Oximeter will 
be decreased, resulting in a calculated versus measured arterial 
“percent O2 saturation gap.” This finding is not specific for methemo­
globinem ia, however, since carboxyhem oglobinem ia and 
sulfhemoglobinemia produce the same findings.
Percent O2 saturation determined with a pulse oximeter may be 
unreliable in patients with methemoglobinemia, especially after 
administration of methylene blue (see Treatment and Management, 
page 13). Arterial blood gases should be used to monitor oxygen­
ation in such patients.
Environmental Indicators
In young infants, drinking water is the most common source of nitrate 
exposure. Water tests for nitrate can be obtained from any public 
health laboratory that utilizes approved EPA procedures. Care 
should be taken to compare the results to the reference units 
provided by the laboratory. Some laboratories report nitrate levels as 
milligrams per liter (mg/L) nitrate; others report nitrate levels as 
mg/L nitrate-nitrogen (NO3-N).
□  Since drinking water is the 
most common source of 
nitrates, testing the water 
supply of patients with a 





(5) In addition to methemoglobinemia, what other clinical conditions may occur from exposure 
to methemoglobin-inducing substances?
(6) What laboratory tests are useful for evaluating a patient with suspected methemoglobinemia?
Treatment and Management
Methylene blue is an 
effective antidote for most 
patients with methemo­
globinemia.
Treatment alone is insuffi­
cient; the nitrate source 
must be identified and 
eliminated from the 
patient's environment.
In cases of mild nitrate toxicity (blood methemoglobin levels less 
than 20%), asymptomatic patients do not require treatment other 
than avoiding ingestion or inhalation of substances that cause met­
hemoglobinemia. In symptomatic patients with moderate or severe 
toxicity and hypoxia or dyspnea, 100% oxygen should be adminis­
tered immediately to fully saturate all remaining normal hemoglobin.
Specific therapy for methemoglobinemia consists of intravenous 
administration of methylene blue at a dose of 1 to 2 milligrams/ 
kilograms (mg/kg) body weight (0.1 to 0.2 milliliters [mL]/kg body 
weight of a 1 % solution in saline) over a 5-to10-minute period. Within 
15 minutes of methylene blue administration, cyanosis will usually 
begin to improve obviously. If no response to the initial injection has 
occurred within 15 minutes in seriously ill patients, or within 30 to 60 
minutes in moderately ill patients, a second methylene blue dose of
0.1 mL/kg body weight may be given. Caution is advised since 
methylene blue can slightly worsen methemoglobinemia when given 
in excessive amounts. In general, the total dose administered during 
the first 2 to 3 hours should not be greater than 0.5 to 0.7 mL/kg of 
body weight.
Methylene blue should not be administered to a patient with known 
G-6-PD deficiency, as severe hemolytic anemia may develop.
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For severe, life-threatening methemoglobinemia, especially when 
the patient responds poorly to methylene blue therapy or when the 
patient is known to have G-6-PD deficiency, treatment options include 
exchange transfusion and hyperbaric oxygen therapy. During treat­
ment in the hyperbaric chamber, sufficient oxygen can be dissolved 
directly in the blood to support life; reversible binding to hemoglobin 
is not required.
Blood transfusion may be required if massive hemolysis develops. 
In persons with severe hemolysis, maintaining a brisk urine flow and 
alkalinizing the urine by administration of sodium bicarbonate may 
help protect against renal injury from erythrocyte breakdown prod­
ucts.
Patients with severe poisoning who are experiencing seizures or 
cardiac arrhythmias may require anticonvulsant or antiarrhythmic 
therapy. If a local anesthetic is suspected of being the etiologic agent 
for the methemoglobinemia, however, lidocaine probably should be 
avoided.
Treatment alone is not adequate for nitrate poisoning. The patient and 
the nitrate source must be permanently separated. In the case of 
infantile acquired methemoglobinemia, well water used in preparing 
formula is a primary etiologic suspect. Physicians and community 
health personnel should be aware that high nitrate levels in water 
supplies may suggest the presence of bacterial contamination or 
agricultural chemicals, which might have serious consequences, 
especially for infants and pregnant women (increased methemoglo- 
bin sensitivity), as well as potential fetal risk. The conventional 
approach of boiling water to destroy microorganisms is not a safe 
practice when nitrate contamination is suspected; evaporation actu­
ally increases the nitrate concentration.
Alternative sources of uncontaminated water may include water from 
a well that has been tested and found to have an acceptable nitrate 
content, bottled water, water from a new and deeper well, or water 
from a regularly monitored public water supply. Water treatment 
technologies (ion exchange resins or reverse osmosis) to remove 
nitrate from water are not adequate to remove other associated 
contaminants, especially coliform bacteria. Private wells should be 




(7) Why might some patients with methemoglobinemia not respond to treatment with methylene 
blue?
(8) What options are available to treat significant methemoglobinemia in a patient known to have 
G-6-PD deficiency?
Standards and Regulations
The nitrate limit in drinking water was established as a safeguard 
against infantile acquired methemoglobinemia. The EPA regulations 
require the nitrate content of potable waterto be below 45 mg/L (45 parts 
per million [ppm]) measured as nitrate (N03_) or 10 mg/L (10 ppm) 
measured as nitrogen in nitrate (N03-N).
15
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other publications in this series, please use the order form on the back cover. For clinical inquiries, contact 
ATSDR, Division of Health Education, Office of the Director, at (404) 639-0730.
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Answers to Pretest and Challenge Questions
Pretest
Pretest questions are on page 1.
(a) In an infant, cyanosis that is unresponsive to oxygen therapy is most likely due to methemoglobinemia.
(b) The clinical laboratory tests that will confirm the diagnosis of methemoglobinemia are blood color and arterial 
blood gases. When a drop of methemoglobin-containing blood is placed on filter paper, it dries a deep 
chocolate-brown or slate-gray color. The level of methemoglobin in the blood can be measured using a Co- 
Oximeter. Analysis of arterial blood gases will reveal normal oxygen pressure.
In the case of infantile acquired methemoglobinemia, well water used to prepare formula should be tested 
for the presence of nitrates. Ingestion of nitrate-containing water is not an uncommon cause of 
methemoglobinemia in infants, especially those residing in rural areas.
(c) The initial step in preventing a recurrence of the infant's cyanosis and distress is to identify the cause of the 
infant's cyanosis; the next step is to correct or eliminate the cause. If the infant is suffering from acquired 
methemoglobinemia, the agent must be identified and removed from the infant’s environment.
Challenge
Challenge questions begin on page 4.
(1) Questions that may help define the cause of the cyanosis include dwelling location; surrounding activities; 
type of sewer system; occupations, avocations, and hobbies of family members; drinking water source and 
supply; in infants, the type of formula, feeding regimen, and source of dilution water; family history, including 
recent use of all medications by both infant and mother; and in infants, a history of recent gastroenteritis.
(2) Causes of high nitrate concentrations in well water include runoff from the use of nitrogen-containing 
agricultural fertilizers (including anhydrous ammonia) and seepage of organic nitrogen-containing material 
from animal wastes or septic sewer systems.
(3) The well water should be tested for nitrate concentration and presence of coliform bacteria. It is most important 
to identify the source of the methemoglobin-inducing agent and to preclude any further exposure to the infant. 
If nitrate-contaminated well water is the source, utilizing bottled or other uncontaminated water to dilute 
formula should be recommended.
You could also recommend frequent testing of the well for nitrate concentration and bacterial contamination, 
or drilling a new and deeper well, taking into consideration the proximity of septic sewer systems, location of 
animal wastes, and proximity to agricultural land that may be regularly treated with nitrogen-based fertilizers.
(4) Infants less than 4 months of age are more susceptible to developing methemoglobinemia because the pH 
of the gut is normally higher than in older children and adults, which enhances the conversion of ingested 
nitrate to the more potent nitrite. The bacterial flora of the young infant's gut is also different from that found 
in older children and adults and may be more likely to convert ingested nitrate to nitrite. Gastroenteritis can 




A large proportion of hemoglobin in young infants is in the form of fetal hemoglobin. Fetal hemoglobin 
is more readily oxidized to methemoglobin by nitrites than is adult hemoglobin. Also, in infants, NADH- 
dependent methemoglobin reductase, the enzyme responsible for reduction of induced methemoglobin 
back to normal hemoglobin, has only about half the activity present in adults.
(5) Hemolytic anemia or sulfhemoglobinemia can be caused by many substances that induce methemoglo­
binemia.
(6) The level of methemoglobinemia can be measured with a Co-Oximeter. Although biologic nitrate and 
nitrite levels can be determined, these tests are not routinely performed; it is more expedient to identify 
and measure nitrate at its source (e.g., contaminated well water).
If congenital methemoglobinemia is suspected or if the patient responds poorly to treatment with 
methylene blue, the following tests should be performed: hemoglobin electrophoresis, G-6-PD activity, 
and the activities of NADH- and NADPH-dependent methemoglobin reductases.
(7) Some patients may not respond to methylene blue treatment because they have a G-6-PD deficiency, 
sulfhemoglobinemia, or hemoglobin M disease.










Continuing education credit is available to health professionals who use this monograph and complete the 
posttest. The criterion for awarding CME credits and CEUs is a posttest score of 70% or better.
The Agency for Toxic Substances and Disease Registry, in joint sponsorship with the Centers for Disease Control 
(CDC), is offering 1 credit hour of continuing medical education (CME) credit in category 1 of the Physician’s 
Recognition Award of the American Medical Association and 0.1 hour of continuing education units (CEU) for 
other health professionals upon completion of this monograph.
The CDC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor 
continuing medical education for physicians, and by the Council on the Continuing Education Unit (CCEU) to 
sponsor continuing education units for other health professionals.
This program has been reviewed and is acceptable for 1 prescribed hour by the American Academy of Family 
Physicians (term of approval: beginning January 1992). For specific information, please consult the AAFP Office 
of Continuing Medical Education.
The American College of Emergency Physicians (ACEP) has approved this program for 1 hour of ACEP Category 
1 credit.
The American Osteopathic Association (AOA) has approved this program for 1 credit hour of Category 2-B AOA- 
CME credit.
To receive continuing education credit (CME or CEUs), complete the Posttest on page 22 in the manner shown 
in the sample question below. Circle all correct answers.
Which of the following is known to precipitate migraine headaches?
After you have finished the Posttest, please transfer your answers to the answer sheet on the inside back cover 
and complete the evaluation on the lower half of that page. Fold, staple, and mail the back cover to Continuing 
Education Coordinator, Agency for Toxic Substances and Disease Registry, Division of Health Education, E33, 
1600 Clifton Road, Atlanta, GA 30333. Your confidential test score will be returned with an indication of where 
the correct answers can be found in the text. Validation of earned CME credit and CEUs will also be forwarded 
to participants, and their names, if requested, will be placed on the mailing list to receive other issues in the Case 









Circle all correct answers and transfer your answers to page 23.
1. Which of the following subpopulations are most at risk of adverse effects from nitrate exposure?
a. pregnant women
b. telephone line workers
c. newborn infants
d. infants less than 4 months of age
e. fetuses
2. Which of the following are possible sources of nitrate exposure?
a. certain topical burn medications
b. shallow domestic wells in rural areas
c. meat preservatives
d. seepage from septic tanks
e. freezer cold packs
3. Which of the following statements about nitrates are true?
a. Nitrates can be converted to nitrites in the gut.
b. The higher alkalinity of an infant's gut protects it from nitrate toxicity.
c. Vomiting and diarrhea can affect the absorption of nitrites.
d. No case of nitrate poisoning has been reported since 1950.
e. Adults are immune from nitrate toxicity if they drink water from public water systems.






5. Which of the following statements are true regarding nitrates?
a. Rapid conversion of nitrates to nitrites occurs mainly in red blood cells.
b. Fecal organisms convert nitrites back to nitrates, thereby protecting adults from toxicity.
c. Nitrites react with deoxyhemoglobin to form Fe3+.
d. Most of an ingested dose is excreted in the urine and saliva.
e. Boiling contaminated water will quickly rid it of nitrates.






7. Which of the following statements are true?
a. Signs and symptoms of methemoglobinemia are roughly correlated with % oxidized hemoglobin.
b. Fetal hemoglobin is more readily oxidized by nitrites than is adult hemoglobin.
c. Methemoglobin causes arterial blood to be blue in color.
d. Cardiac arrythmias and hypotension can result from severe nitrate poisoning.
e. Blood methemoglobin level is the most useful diagnostic test for nitrate toxicity.








CASE STUDIES IN ENVIRONMENTAL MEDICINE: NITRATE/NITRITE TOXICITY
If you wish CME credits or CEUs, please indicate your answers to the Posttest questions on page 22 by circling 
the letters below for the correct answers. Complete the evaluation questionnaire and fill in the information 
requested on the reverse side. Tear off this last page, fold, staple, and mail to Continuing Education Coordinator, 
Agency forToxic Substances and Disease Registry, Division of Health Education, E33,1600 Clifton Road, Atlanta, 
GA 30333.
1. a b c d e
2. a b c d e
3. a b c d e
4. a b c d e
5. a b c d e
6. a b c d e
7. a b c d e
8. a b c d e
Evaluation Questionnaire
Please complete the following evaluation by circling your response.
1. Was the breadth of information in this issue sufficient for your needs?
Yes No Undecided
2. Was the amount of detail appropriate?
Too technical Just right Not technical enough
3. As a result of reading this issue, will you now ask paiients more questions regarding possible 
environmental exposures?
Yes No Undecided Not applicable
4. Would you recommend this issue to your colleagues?
Yes No Undecided
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The state of knowledge regarding the treatment of patients potentially exposed to 
hazardous substances in the environment is constantly evolving and often uncertain. In 
this monograph, the Agency for Toxic Substances and Disease Registry (ATSDR) has 
made diligent effort to ensure the accuracy and currency of the Information presented 
but makes no claim that the document comprehensively addresses all possible 
situations related to this substance. This monograph Is intended as an additional 
resource for physicians and other health professionals In assessing the condition and 
managing the treatment of patients potentially exposed to hazardous substances. It Is 
not, however, a substitute for the professional judgment of a health care provider and 
must be Interpreted In light of specific information regarding the patient available to such 
a professional and in conjunction with other sources of authority.
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